
Sign up to save your podcasts
Or


In this episode, Coral’s Founder Meg Koepke talks with Alison Falb about her journey from CMS to FDA to Coral. We explore current policy trends and challenges in Life Sciences –what they mean for organizations navigating drug pricing reforms, coverage, and access challenges.
By Meg and MelissaIn this episode, Coral’s Founder Meg Koepke talks with Alison Falb about her journey from CMS to FDA to Coral. We explore current policy trends and challenges in Life Sciences –what they mean for organizations navigating drug pricing reforms, coverage, and access challenges.